Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382934516> ?p ?o ?g. }
- W4382934516 endingPage "656" @default.
- W4382934516 startingPage "650" @default.
- W4382934516 abstract "The purpose of this study was to investigate treatment outcomes of chemoradiotherapy (CRT) using S-1 with or without conversion surgery after gemcitabine plus nab-paclitaxel (GnP) for borderline resectable (BR) and unresectable locally advanced (UR-LA) pancreatic cancer.From 2016 to 2020, patients without disease progression after GnP for BR or UR-LA pancreatic cancer underwent CRT with S-1. If distant metastasis was not detected after CRT, conversion surgery and oral administration of S-1 as postoperative adjuvant chemotherapy for at least 6 months was performed.Forty patients were included in the present study. The median number of cycles of GnP was 6. Surgery was performed after CRT in 25 patients. The median progression-free survival (PFS) and overall survival (OS) periods from the start of radiotherapy were 24.6 and 27.4 months, respectively. The OS periods from the start of radiotherapy in patients who underwent conversion surgery and those who did not undergo conversion surgery were 41.3 and 16.8 months, respectively. The PFS periods from the start of radiotherapy in patients who underwent surgery and those who did not undergo surgery were 28.3 and 8.6 months, respectively. Patients who were able to receive S-1 after conversion surgery for more than 6 months had better OS than those who were not (p = 0.039), although there was no significant difference of PFS (p = 0.365).In BR/UR-LA pancreatic cancer without disease progression after GnP, multimodal treatment including CRT, conversion surgery and the scheduled postoperative chemotherapy may be effective." @default.
- W4382934516 created "2023-07-04" @default.
- W4382934516 creator A5004119000 @default.
- W4382934516 creator A5004640817 @default.
- W4382934516 creator A5006867334 @default.
- W4382934516 creator A5007855678 @default.
- W4382934516 creator A5011710526 @default.
- W4382934516 creator A5016487480 @default.
- W4382934516 creator A5027528437 @default.
- W4382934516 creator A5027803701 @default.
- W4382934516 creator A5039379517 @default.
- W4382934516 creator A5086139902 @default.
- W4382934516 date "2023-09-01" @default.
- W4382934516 modified "2023-09-27" @default.
- W4382934516 title "Clinical impact of multimodal treatment including chemoradiotherapy, conversion surgery and postoperative chemotherapy for borderline resectable and unresectable locally advanced pancreatic cancer without disease progression after gemcitabine plus nab-paclitaxel" @default.
- W4382934516 cites W1592992548 @default.
- W4382934516 cites W1955000909 @default.
- W4382934516 cites W1965195700 @default.
- W4382934516 cites W2073667430 @default.
- W4382934516 cites W2093115033 @default.
- W4382934516 cites W2103711657 @default.
- W4382934516 cites W2118797060 @default.
- W4382934516 cites W2130409622 @default.
- W4382934516 cites W2138582833 @default.
- W4382934516 cites W2151253787 @default.
- W4382934516 cites W2153704693 @default.
- W4382934516 cites W2155155934 @default.
- W4382934516 cites W2155657391 @default.
- W4382934516 cites W2165480504 @default.
- W4382934516 cites W2172089182 @default.
- W4382934516 cites W2323248054 @default.
- W4382934516 cites W2345822778 @default.
- W4382934516 cites W2346921980 @default.
- W4382934516 cites W2412717755 @default.
- W4382934516 cites W2528162187 @default.
- W4382934516 cites W2556845430 @default.
- W4382934516 cites W2770835903 @default.
- W4382934516 cites W2898193720 @default.
- W4382934516 cites W2908165114 @default.
- W4382934516 cites W2912196744 @default.
- W4382934516 cites W2926499479 @default.
- W4382934516 cites W2971438153 @default.
- W4382934516 cites W2982947522 @default.
- W4382934516 cites W3000487074 @default.
- W4382934516 cites W3008190574 @default.
- W4382934516 cites W3011344476 @default.
- W4382934516 cites W3047544401 @default.
- W4382934516 cites W3084128148 @default.
- W4382934516 cites W3085588957 @default.
- W4382934516 cites W3099619125 @default.
- W4382934516 cites W3161080579 @default.
- W4382934516 cites W3188457669 @default.
- W4382934516 cites W3201340208 @default.
- W4382934516 cites W4211208840 @default.
- W4382934516 cites W4292583803 @default.
- W4382934516 doi "https://doi.org/10.1016/j.pan.2023.07.002" @default.
- W4382934516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37453848" @default.
- W4382934516 hasPublicationYear "2023" @default.
- W4382934516 type Work @default.
- W4382934516 citedByCount "0" @default.
- W4382934516 crossrefType "journal-article" @default.
- W4382934516 hasAuthorship W4382934516A5004119000 @default.
- W4382934516 hasAuthorship W4382934516A5004640817 @default.
- W4382934516 hasAuthorship W4382934516A5006867334 @default.
- W4382934516 hasAuthorship W4382934516A5007855678 @default.
- W4382934516 hasAuthorship W4382934516A5011710526 @default.
- W4382934516 hasAuthorship W4382934516A5016487480 @default.
- W4382934516 hasAuthorship W4382934516A5027528437 @default.
- W4382934516 hasAuthorship W4382934516A5027803701 @default.
- W4382934516 hasAuthorship W4382934516A5039379517 @default.
- W4382934516 hasAuthorship W4382934516A5086139902 @default.
- W4382934516 hasBestOaLocation W43829345161 @default.
- W4382934516 hasConcept C121608353 @default.
- W4382934516 hasConcept C126322002 @default.
- W4382934516 hasConcept C141071460 @default.
- W4382934516 hasConcept C143998085 @default.
- W4382934516 hasConcept C2776694085 @default.
- W4382934516 hasConcept C2777292972 @default.
- W4382934516 hasConcept C2777299880 @default.
- W4382934516 hasConcept C2778424827 @default.
- W4382934516 hasConcept C2780210213 @default.
- W4382934516 hasConcept C2780258809 @default.
- W4382934516 hasConcept C4441509 @default.
- W4382934516 hasConcept C509974204 @default.
- W4382934516 hasConcept C71924100 @default.
- W4382934516 hasConceptScore W4382934516C121608353 @default.
- W4382934516 hasConceptScore W4382934516C126322002 @default.
- W4382934516 hasConceptScore W4382934516C141071460 @default.
- W4382934516 hasConceptScore W4382934516C143998085 @default.
- W4382934516 hasConceptScore W4382934516C2776694085 @default.
- W4382934516 hasConceptScore W4382934516C2777292972 @default.
- W4382934516 hasConceptScore W4382934516C2777299880 @default.
- W4382934516 hasConceptScore W4382934516C2778424827 @default.
- W4382934516 hasConceptScore W4382934516C2780210213 @default.
- W4382934516 hasConceptScore W4382934516C2780258809 @default.
- W4382934516 hasConceptScore W4382934516C4441509 @default.
- W4382934516 hasConceptScore W4382934516C509974204 @default.
- W4382934516 hasConceptScore W4382934516C71924100 @default.